Biles, meanwhile, was given methylphenidate for attention-deficit disorder.
The transformation once our children were given methylphenidate was profound.
The researchers gave methylphenidate to 24 marijuana abusers (who had smoked a median of about five joints a day, 5 days a week, for 10 years) and 24 controls.
Health authorities have given methylphenidate the same drug classification as amphetamines and they both perform similar to each other in traditional assays of abuse [ 280, 281].
The ADHD participants were randomized into three groups, with 30 in the NF group, 31 controls in a group that was given methylphenidate, and 30 in a group that received NF and methylphenidate.
In the experiment, 36 volunteers without prior experience with hallucinogens were given psilocybin and methylphenidate (Ritalin) in separate sessions; the methylphenidate sessions served as a control and psychoactive placebo.
The fact remains that there may be a growing awareness that giving amphetamine and methylphenidate-based drugs to young children may not be without some problems.
To make matters worse, on Oct. 16, 2011 the American Academy of Pediatrics overrode the FDA and recommended that children as young as age four be diagnosed with ADHD and given the stimulant methylphenidate (e.g., Ritalin, Metadate, Focalin, Daytrana and Concerta).
In a randomized, double-blind, cross-over study comparing the effect of methylphenidate (given thrice daily) and atomoxetine (given twice daily) on the sleep of children with ADHD, methylphenidate increased sleep-onset latency significantly more than did atomoxetine, both considering actigraphic and polysomnographic data [ 123].
Even the trials originally considered at low risk of bias may in fact be trials with high risk of bias owing to lack of blinding despite the use of placebo, as methylphenidate gives rise to several easily recognisable adverse events that can lead to loss of blinding and influence the rating of symptoms and adverse events.
